Delivery Order SPE2DB22D3016-SPE2DB25FBGY5
- Not listed
- The Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 5, 2025, for the supply of Tetracaine 0.5% Steri-Unit Solution in 4ml units. This contract, valued at $3,539.90, represents a firm fixed price delivery order with no set-aside designation, indicating competitive award. The contract is classified as a child contract and executed through AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical,...
- The Defense Logistics Agency awarded a delivery order valued at $1,389.36 to AmerisourceBergen Drug Corp on July 18, 2025, for Tetracaine 0.5% Steri-Unit Solution in 4mL units. This is a firm fixed price, competitively awarded contract with no set-aside designation and an ultimate completion date of July 21, 2025. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child contract under AmerisourceBergen's...
- The Defense Logistics Agency awarded a $2,094.60 firm fixed-price delivery order to AmerisourceBergen Drug Corp on September 3, 2025, for the supply of Tetracaine 0.5% Steri-Unit Solution in 4-milliliter units. The contract, which represents a child award under AmerisourceBergen's larger federal contract vehicle, is scheduled for completion by September 4, 2025, with performance taking place at the company's corporate office in Conshohocken, Pennsylvania. This delivery order was competitively...
- The Defense Logistics Agency awarded a delivery order valued at $2,038.68 to AmerisourceBergen Drug Corp for Tetracaine 0.5% Steri-Unit Solution in 4 milliliter units. This firm fixed price delivery order, executed on August 21, 2025, with an ultimate completion date of August 22, 2025, represents a non-set-aside competitive award. The product will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order valued at $2,038.68 to AmerisourceBergen Drug Corp on July 25, 2025, for the supply of Tetracaine 0.5% Steri-Unit Solution in 4 mL units, with an ultimate completion date of July 28, 2025. This contract award is not set-aside and utilizes firm fixed pricing under a competitive delivery order arrangement. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform this work at its corporate office location. The...
- The Defense Logistics Agency awarded a delivery order valued at $1,582.65 to AmerisourceBergen Drug Corp for Tetracaine 0.5% Steri-Unit Solution 4ML, a pharmaceutical product for military medical supply needs. This competitively awarded, firm fixed price contract was executed on August 13, 2025, with an ultimate completion date of August 14, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. No set-aside designation was used for this procurement. This...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,194.61 to AmerisourceBergen Drug Corp for the supply of Tetracaine 0.5% Steri-Unit Solution in 4ML quantities. This is a firm fixed-price delivery order with an ultimate completion date of August 13, 2025, and was awarded competitively without set-aside designation. The product will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, for the supply of 4,563,988,146 units of 0.5% Tetracaine Steri-Unit Solution (4 mL). The contract has an ultimate completion date of March 18, 2024 and a ceiling value of $3,087.08. This delivery order is part of a larger indefinite delivery contract (IDC) awarded to AmerisourceBergen Drug Corp by DLA, with a potential value...
- The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order contract to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, for the supply of 0.5% tetracaine sterile solution products. The $1,744.20 award has a period of performance through March 12, 2024. AmerisourceBergen Drug Corp is the prime contractor and no set-aside designation was used. This delivery order falls under a larger indefinite delivery contract (IDC)...
- The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical company Amerisourcebergen Corporation. The contract, valued at $2,626.78, is for the provision of 0.5% Tetracaine Steri-Unit Solution in 4 mL vials. This order is part of a larger indefinite delivery contract (IDC) valued at up to $999,999,999.00 through December 31, 2025, which serves as the primary vehicle for...
- SPE2DB22D3016Indefinite Delivery Contract
- SPE2DB22D3016-SPE2DB25FBGY5Delivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 2, 2025, for the supply of Tetracaine 0.5% Steri-Unit Solution in 4ml units, with a ceiling value of $3,441.49. This firm fixed-price delivery order, which is not subject to any set-aside designation, represents a competitive award under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical. The contract vehicle, designated SPE2DX, is valued at $999,999,999.00 and extends through December 2026, serving as a comprehensive global pharmaceutical support mechanism for military healthcare programs worldwide. Performance of this delivery order is based in Conshohocken, Pennsylvania, with an ultimate completion date of September 3, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, serves as a critical vendor for federal medical procurement through its extensive portfolio of pharmaceutical products and medical supplies. The company's DLA IDC enables it to supply a wide range of medications, vaccines, medical devices, and specialized healthcare commodities across multiple therapeutic domains in support of the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. This delivery order for local anesthetic pharmaceutical supplies reflects the company's ongoing role in supporting military and federal healthcare operations.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.4k | 9/2/25 |